Síntesis de nitroderivados de hidroxitirosol como potenciales inhibidores de COMT. Article in Basic & Clinical Pharmacology & Toxicology · January . The principle aim of COMT inhibitor therapy is to increase the duration of El principal objetivo del tratamiento con inhibidores de la COMT es. AMPT: α-metil-p-tirosina; COMT: catecol-O- . gena en la circulación, primero son metiladas por la COMT y con- Existen también inhibidores de la COMT.

Author: Yozshugore Yohn
Country: Tunisia
Language: English (Spanish)
Genre: Medical
Published (Last): 16 January 2007
Pages: 76
PDF File Size: 12.66 Mb
ePub File Size: 12.19 Mb
ISBN: 268-1-28352-893-5
Downloads: 67951
Price: Free* [*Free Regsitration Required]
Uploader: Mikatilar

ES2282924T3 – Inhibidores de la comt. – Google Patents

Levodopaa precursor of catecholamines, is an important substrate of COMT. December Learn how and when to remove this template message. It is increasingly recognised that allelic variation at the COMT gene are also relevant for emotional processing, as they seem to influence the interaction between prefrontal and limbic regions. All articles with dead external links Articles with dead external links from November Articles with permanently dead external links Articles lacking reliable references from December All articles lacking reliable references Commons category link is on Wikidata.

The gene variant has been shown to affect cognitive tasks broadly related to executive functionsuch as set shifting, response inhibition, abstract thought, and the acquisition of rules or task structure. Lay summary — MedWireNews. Two of the nitrocatechols, entacapone Histamine Lz Diamine oxidase.


Cholinesterase AcetylcholinesteraseButyrylcholinesterase. The best-studied is ValMet. From Wikipedia, the free encyclopedia. Retrieved November 16, When given with an inhibitor of dopa decarboxylase carbidopa or benserazidelevodopa is optimally saved.

Journal of Oral Rehabilitation. As the regulation of catecholamines is impaired in a number of medical conditions, several pharmaceutical drugs target COMT to alter its activity and therefore the availability of catecholamines. The O in the name stands for oxygennot for ortho.

Phosphoribosylglycinamide formyltransferase Inosine monophosphate synthase. Thus, COMT inhibitors are clinically significant and beneficial adjunct to levodopa therapy in Parkinson’s disease patients with end-of-dose fluctuations. Neurotransmitters and their receptors”. The Journal of Biological Chemistry. Comparable effects on similar cognitive tasks, the frontal fe, and the neurotransmitter dopamine have also all been linked to schizophrenia.

However, there seems to be a trend for tolcapone to induce more often diarrhoea and increase in liver transaminases compared with entacapone. Molecular and Cellular Biology portal.

Both entacapone and tolcapone are well-tolerated. Catechol- O -methyltransferase is involved lz the inactivation of the catecholamine neurotransmitters dopamineepinephrineand norepinephrine. The dyskinesias are managed by decreasing the daily levodopa dose in Parkinson’s disease patients with end-of-dose fluctuations.


Hydroxymethyltransferase Serine hydroxymethyltransferase 3-methyloxobutanoate hydroxymethyltransferase.

Catechol-O-methyltransferase – Wikipedia

Catechol-O-methyl transferase Monoamine oxidase A B. Genetic variation with functional impact on cortical dopamine tone has a strong influence on injibidores experience in the flow of daily life.

By using this site, you agree to the Terms of Use and Privacy Policy. More reference expression data.

COMT inhibition in the treatment of Parkinson’s disease.

American Cmot of Human Genetics. This page was last edited on 21 Novemberat Goetz CG May Chromosome 22 human [1]. Any compound having a catechol structure, like catecholestrogens and catechol-containing flavonoids, are substrates of COMT.

This “triple therapy” is becoming a standard in the treatment of Parkinson’s disease. EC number Enzyme superfamily Enzyme family List of enzymes. COMT inhibitors include tolcaponeentacapone and opicaponewhich are used in the treatment of Parkinson’s disease.